Answers are grounded in this paper and cite their sources.
Combination therapy demonstrates safety and efficacy in advanced undifferentiated pleomorphic sarcoma.
The combination of epirubicin, ifosfamide, and nivolumab is a safe, feasible, and highly active treatment for advanced UPS.
No takes yet. Share an insight, caveat, or question.
Martin-Broto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: